These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33955555)

  • 1. Viral hepatitis in haemophilia: historical perspective and current management.
    Isfordink CJ; van Erpecum KJ; van der Valk M; Mauser-Bunschoten EP; Makris M
    Br J Haematol; 2021 Oct; 195(2):174-185. PubMed ID: 33955555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion-transmitted disease.
    Lee CA
    Baillieres Clin Haematol; 1996 Jun; 9(2):369-94. PubMed ID: 8800511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of hepatitis C-infected haemophilia patients is predicted by presence of cirrhosis but not by anti-viral treatment.
    Maor Y; Schapiro JM; Bashari D; Martinowitz U
    Ann Hepatol; 2014; 13(6):753-61. PubMed ID: 25332261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C infection among Dutch haemophilia patients: a nationwide cross-sectional study of prevalence and antiviral treatment.
    Posthouwer D; Plug I; van der Bom JG; Fischer K; Rosendaal FR; Mauser-Bunschoten EP
    Haemophilia; 2005 May; 11(3):270-5. PubMed ID: 15876273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GB virus C/hepatitis G virus infection in HIV infected patients with haemophilia despite treatment with virus inactivated clotting factor concentrates.
    Woelfle J; Berg T; Bialek R; Keller KM; Effenberger W; Wagner N
    Arch Dis Child; 1999 May; 80(5):429-32. PubMed ID: 10208947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical spectrum of viral infections in hemophilic patients.
    Telfer MC
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1047-56. PubMed ID: 1328142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of viral safety of coagulation factor VIII and IX concentrates.
    Mannucci PM
    Vox Sang; 1993; 64(4):197-203. PubMed ID: 8517048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood-transmitted viral infections among haemophiliacs in Tunisia].
    Langar H; Triki H; Gouider E; Bahri O; Djebbi A; Sadraoui A; Hafsia A; Hafsia R
    Transfus Clin Biol; 2005 Oct; 12(4):301-5. PubMed ID: 16099190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C in haemophilia: lights and shadows.
    Rumi MG; De Filippi F; Santagostino E; Colombo M
    Haemophilia; 2004 Oct; 10 Suppl 4():211-5. PubMed ID: 15479400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of conditions associated with human immunodeficiency and hepatitis virus infections among persons with haemophilia, 2001-2003.
    Goedert JJ;
    Haemophilia; 2005 Sep; 11(5):516-28. PubMed ID: 16128897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral pathogens.
    Ragni MV; Sherman KE; Jordan JA
    Haemophilia; 2010 Jul; 16 Suppl 5():40-6. PubMed ID: 20590855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis C antibodies in patients with clotting disorders in Victoria. Relationship with other blood borne viruses and liver disease.
    Leslie DE; Rann S; Nicholson S; Fairley CK; Gust ID
    Med J Aust; 1992 Jun; 156(11):789-92. PubMed ID: 1321326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recommendations of Gesida/PNS/AEEH for the management and treatment of the adult patient co-infected with HIV and hepatitis A, B and C virus].
    Panel de expertos de Gesida, Secretaría del Plan Nacional sobre el Sida (SPNS) y Asociación Española para el Estudio del Hígado (AEEH)
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):31.e1-31. PubMed ID: 20116629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure in persons with haemophilia with a focus on haemophilia-specific risk factors.
    Ter-Zakarian A; Barnes RFW; Kruse-Jarres R; Quon DV; Jackson S; Sun HL; von Drygalski A
    Haemophilia; 2022 Nov; 28(6):977-985. PubMed ID: 35768896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis and HIV infection during haemodialysis.
    Saha D; Agarwal SK
    J Indian Med Assoc; 2001 Apr; 99(4):194-9, 203, 213. PubMed ID: 11666025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation.
    Darby SC; Ewart DW; Giangrande PL; Spooner RJ; Rizza CR; Dusheiko GM; Lee CA; Ludlam CA; Preston FE
    Lancet; 1997 Nov; 350(9089):1425-31. PubMed ID: 9371165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes, hepatitis C and human immunodeficiency virus influence hypertension risk differently in cohorts of haemophilia patients, veterans and the general population.
    Barnes RFW; Pandey B; Sun HL; Jackson S; Kruse-Jarres R; Quon DV; von Drygalski A
    Haemophilia; 2022 Nov; 28(6):e228-e236. PubMed ID: 35877992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of transfusion-associated virus infections in hemophilic patients needing replacement therapy].
    Meili EO
    Beitr Infusionsther; 1989; 24():46-55. PubMed ID: 2481548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood safety monitoring among persons with bleeding disorders--United States, May 1998-June 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Jan; 51(51-52):1152-4. PubMed ID: 12553567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic hepatitis in haemophilia.
    Makris M; Preston FE
    Blood Rev; 1993 Dec; 7(4):243-50. PubMed ID: 7510563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.